Cite
HARVARD Citation
Senesse, P. et al. (n.d.). SUN-LB280: Double Blind Multicenter Phase III Gortec Trial Evaluating the Efficacy of Oral Immune Modulating Formulae Therapy During Adjuvant Chemoradiotherapy in Head and Neck Squamous Cell Carcinoma (HNSCC). Clinical nutrition. pp. S148-S149. [Online].